Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8712 |
High Similarity |
NPD4908 |
Phase 1 |
0.8605 |
High Similarity |
NPD1610 |
Phase 2 |
0.8593 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8593 |
High Similarity |
NPD1613 |
Approved |
0.8583 |
High Similarity |
NPD1548 |
Phase 1 |
0.8582 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD1091 |
Approved |
0.8433 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8358 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8222 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8194 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.8102 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.806 |
Intermediate Similarity |
NPD4749 |
Approved |
0.8043 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.791 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7891 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7891 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7862 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7847 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7793 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7762 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7718 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7716 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7712 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7712 |
Intermediate Similarity |
NPD37 |
Approved |
0.7708 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7677 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7677 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7662 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7656 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7652 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7639 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7628 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7593 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7582 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD290 |
Approved |
0.7568 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7564 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7552 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7548 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7518 |
Intermediate Similarity |
NPD3705 |
Approved |
0.75 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD968 |
Approved |
0.75 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5126 |
Approved |
0.75 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7482 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7469 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7466 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.746 |
Intermediate Similarity |
NPD940 |
Approved |
0.746 |
Intermediate Similarity |
NPD846 |
Approved |
0.745 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7447 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7424 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7417 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7415 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7415 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7415 |
Intermediate Similarity |
NPD2796 |
Approved |
0.741 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7397 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7388 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7372 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7372 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7333 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD2801 |
Approved |
0.731 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7305 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7303 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7254 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7234 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7233 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7219 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7214 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7211 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5494 |
Approved |
0.719 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7188 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD3268 |
Approved |
0.717 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7163 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7123 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7117 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7114 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7111 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7105 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1772 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7075 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7041 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD821 |
Approved |
0.7034 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7027 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7024 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7018 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD2557 |
Approved |
0.7 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD5929 |
Approved |
0.7 |
Intermediate Similarity |
NPD3846 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6984 |
Remote Similarity |
NPD2934 |
Approved |
0.6984 |
Remote Similarity |
NPD2933 |
Approved |
0.698 |
Remote Similarity |
NPD3054 |
Approved |
0.698 |
Remote Similarity |
NPD3052 |
Approved |
0.6978 |
Remote Similarity |
NPD6580 |
Approved |
0.6978 |
Remote Similarity |
NPD6581 |
Approved |
0.6978 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6977
|
Remote Similarity |
NPD1242 |
Phase 1 |